• Home
  • Interventional Vascular Therapy
  • Access Port Systems
  • Access Ports
  • Venous Access Ports

  • Celsite® Discreet

Celsite® Discreet
Venous access ports with unique design for enhanced port stability and better cosmetic results

Celsite® Discreet Access Port Systems are indicated for any condition that requires mid to long-term intermittent or continuous venous infusion.
They are intended to be used for repeated, intravenous administration of, for example, chemotherapy, antibiotic and anti-viral drugs, parenteral nutrition, blood sampling or transfusion.

The patented 90° angle of the Celsite® Discreets exit cannula reduces the risk of port flip and associated blockage due to catheter kinking. In addition, the special port design supports a vertical incision for a faster wound healing with a more discreet scar.
 

Special Features

  • Prevention of port flip due to patented 90° angle of the exit cannula
  • Supports a vertical incision for a faster wound healing with a more discreet scar
  • Compact port design with enlarged puncture area in relation to the port housing size
  • Available with radiopaque "CT" marking (except for the US market) which indicates power injectability of the port on x-ray
  • High pressure resistance up to 325 PSI ( 22,4 bar)
     

General Features

  • Only 1 suture hole is needed for port fixation due to reduced port flip risk
  • Titanium chamber for enhanced security
  • Also available in small sizes to facilitate implantation in paediatric and underweight patients
  • High density silicone septum for reliable puncture and to ensure maximum port life
  • The radiopaque catheter is graduated from 5 cm in order to facilitate an easy, precise and safe implantation
  • Rounded atraumatic catheter tip
  • Reliable radiopaque connection ring with anti-kink protection
  • MRI compatible, Latex, DEHP and PVC free
     

Available Implantation Technique

  • Seldinger
     
Read more

Celsite® Discreet Access Port Systems are indicated for any condition that requires mid to long-term intermittent or continuous venous infusion.
They are intended to be used for repeated, intravenous administration of, for example, chemotherapy, antibiotic and anti-viral drugs, parenteral nutrition, blood sampling or transfusion.

The patented 90° angle of the Celsite® Discreets exit cannula reduces the risk of port flip and associated blockage due to catheter kinking. In addition, the special port design supports a vertical incision for a faster wound healing with a more discreet scar.
 

Special Features

  • Prevention of port flip due to patented 90° angle of the exit cannula
  • Supports a vertical incision for a faster wound healing with a more discreet scar
  • Compact port design with enlarged puncture area in relation to the port housing size
  • Available with radiopaque "CT" marking (except for the US market) which indicates power injectability of the port on x-ray
  • High pressure resistance up to 325 PSI ( 22,4 bar)
     

General Features

  • Only 1 suture hole is needed for port fixation due to reduced port flip risk
  • Titanium chamber for enhanced security
  • Also available in small sizes to facilitate implantation in paediatric and underweight patients
  • High density silicone septum for reliable puncture and to ensure maximum port life
  • The radiopaque catheter is graduated from 5 cm in order to facilitate an easy, precise and safe implantation
  • Rounded atraumatic catheter tip
  • Reliable radiopaque connection ring with anti-kink protection
  • MRI compatible, Latex, DEHP and PVC free
     

Available Implantation Technique

  • Seldinger